Evaluation of the long-term safety and tolerability of cariprazine in patients with schizophrenia: results from a 1-year open-label study (original) (raw)

Psychopharmacology, 2017

Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia: a pooled analysis of four phase II/III randomized, double-blind, placebo-controlled studies

Marc Debelle

International clinical psychopharmacology, 2017

Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in Therapy

Advances in Therapy, 2013

Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel

Alessandro Cuomo

Annals of General Psychiatry, 2020

The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis

BMC Psychiatry, 2017

Cariprazine for the Treatment of Schizophrenia: A Review of this Dopamine D3-Preferring D3/D2 Receptor Partial Agonist

Clinical Schizophrenia & Related Psychoses, 2016

Cariprazine, A Broad-Spectrum Antipsychotic for the Treatment of Schizophrenia: Pharmacology, Efficacy, and Safety

Advances in Therapy, 2021

Efficacy of cariprazine across symptom domains in patients with acute exacerbation of schizophrenia: Pooled analyses from 3 phase II/III studies

European Neuropsychopharmacology, 2018

An evaluation of the safety and efficacy of cariprazine in patients with acute exacerbation of schizophrenia: A phase II, randomized clinical trial

Schizophrenia Research, 2014

Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

Neuropsychiatric Disease and Treatment, 2018

The preclinical discovery and development of cariprazine for the treatment of schizophrenia

Marcin Kołaczkowski

Expert Opinion on Drug Discovery, 2018

The efficacy and safety of cariprazine in the early and late stage of schizophrenia: a post hoc analysis of three randomized, placebo-controlled trials

CNS Spectrums, 2021

Cariprazine in acute exacerbation of schizophrenia: a fixed-dose, phase 3, randomized, double-blind, placebo- and active-controlled trial

The Journal of clinical psychiatry, 2015

Cariprazine in the management of negative symptoms of schizophrenia: state of the art and future perspectives

Swaran Preet Singh

Future Neurology, 2020

Cariprazine in the treatment of schizophrenia

International Clinical Psychopharmacology, 2016

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms

Octavian Vasiliu

Frontiers in Psychiatry, 2021

Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial

Schizophrenia research, 2016

Dosing Cariprazine Within and Beyond Clinical Trials: Recommendations for the Treatment of Schizophrenia

Elmars Rancans

Frontiers in Psychiatry, 2022

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies

Barbara Sebe

Neuropsychiatric Disease and Treatment

Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients With Schizophrenia or Bipolar Mania

Julie Passarell

Clinical and Translational Science, 2019

Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment

Alexey Pavlichenko

Consortium Psychiatricum, 2020

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine

Borjanka Batinić

Frontiers in Psychiatry, 2021

Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis

Robert Litman

International journal of clinical practice, 2017

Cariprazine in Bipolar Disorder: Clinical Efficacy, Tolerability, and Place in Therapy

Advances in Therapy, 2013

Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials

Lakshmi Yatham

Frontiers in Psychiatry, 2021

Effect of cariprazine on the 6 domains of schizophrenia in ICD-11: a narrative review

Alexey Pavlichenko

Consortium Psychiatricum, 2022

Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials

Frank Besag

CNS drugs, 2016

Symptomatic Profi le of Cariprazine in the Context of ICD-11 Domains for Schizophrenia: Review of Clinically Oriented Studies

Alexey Pavlichenko

2022

Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies

Journal of affective disorders, 2017

Clinical potential of cariprazine in the treatment of acute mania

E. Timuçin Oral

Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials

Marc Debelle

European Neuropsychopharmacology, 2015

Clinical Global Impression of Cariprazine in Negative Symptom Schizophrenia Patients: Comparison of clinical trial data vs. real-world evidence

European Psychiatry